PRAN - Alterity Therapeutics Limited

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.0100
0.0000 (0.00%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Trade prices are not sourced from all markets
Previous Close2.0100
Open2.0300
Bid0.0000 x 1000
Ask0.0000 x 1200
Day's Range1.9300 - 2.0700
52 Week Range1.0900 - 2.9100
Volume15,298
Avg. Volume108,113
Market Cap17.284M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Why Prana Biotechnology Stock Is Skyrocketing Today
    InvestorPlace5 months ago

    Why Prana Biotechnology Stock Is Skyrocketing Today

    This strategic investment from Life Biosciences will have it making an initial investment of $7.5 million into the company researching treatments for Parkinson’s disease. After this initial investment, the company will also be able to raise an additional $21.9 million from Life Biosciences and other investors. The deal will have the company issuing 272 million new fully paid ordinary shares of Prana Biotechnology stock.

  • TheStreet.com5 months ago

    Prana Biotech Surges on Promised $31.4 Million Investment

    -- a biotech company working on therapies for debilitating neurological disease -- saw its shares shoot up some up 50% to $1.92 on Wednesday, Jan. 2, after getting a promised $31.4 million investment. Boston-based Life Biosciences, a private biopharmaceutical company, is seeking the stake in Prana, and will also lend at least two new big-name board members to the Australia-based drug developer. In total, Life Biosciences could own up to 60% of Prana when the deal is completed.

  • Simply Wall St.5 months ago

    Is Prana Biotechnology Limited’s (ASX:PBT) CEO Pay Justified?

    Geoffrey Kempler has been the CEO of Prana Biotechnology Limited (ASX:PBT) since 2005. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of Read More...

  • Simply Wall St.7 months ago

    How Financially Strong Is Prana Biotechnology Limited (ASX:PBT)?

    Prana Biotechnology Limited (ASX:PBT), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital. However, the trade-off is PBT Read More...